Donepezil News and Research

RSS
Donepezil is a drug that is used to treat Alzheimer disease and is being studied in the treatment of side effects caused by radiation therapy to the brain. It is a type of cholinesterase inhibitor.
Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

World Alzheimer’s Day 2019: A timely reminder of urgent need for new drugs to tackle disease

World Alzheimer’s Day 2019: A timely reminder of urgent need for new drugs to tackle disease

Alzheimer's drug associated with two-fold higher risk of hospitalization for rhabdomyolysis

Alzheimer's drug associated with two-fold higher risk of hospitalization for rhabdomyolysis

Alzheimer's drug reverses brain damage in rats exposed to alcohol during adolescence

Alzheimer's drug reverses brain damage in rats exposed to alcohol during adolescence

Chemotherapy may increase survival for advanced colon cancer patients with dementia, study suggests

Chemotherapy may increase survival for advanced colon cancer patients with dementia, study suggests

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients

Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients

Study compares risk of pneumonia linked to using different antidementia drugs

Study compares risk of pneumonia linked to using different antidementia drugs

Novel therapeutic strategy could target multiple aspects of Alzheimer's disease

Novel therapeutic strategy could target multiple aspects of Alzheimer's disease

FDA-approved Alzheimer's medications may help people quit smoking

FDA-approved Alzheimer's medications may help people quit smoking

Estrogen-like drug may not be beneficial to women with Alzheimer's dementia

Estrogen-like drug may not be beneficial to women with Alzheimer's dementia

Cholinesterase inhibitor delays nursing home admission in late-stage AD

Cholinesterase inhibitor delays nursing home admission in late-stage AD

First patients screened in Axovant's phase 3 study of RVT-101

First patients screened in Axovant's phase 3 study of RVT-101

Common Alzheimer's disease drug increases bone density, reduces fracture risks

Common Alzheimer's disease drug increases bone density, reduces fracture risks

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Anti-dementia drugs could result in harmful weight loss, say researchers

Anti-dementia drugs could result in harmful weight loss, say researchers

Axovant Sciences accepts two presentations at Alzheimer's Association International Conference 2015

Axovant Sciences accepts two presentations at Alzheimer's Association International Conference 2015

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

Nicotine metabolite supports learning, memory by amplifying action of primary chemical messenger

Nicotine metabolite supports learning, memory by amplifying action of primary chemical messenger

Actavis provides overview of standalone global pharmaceutical development pipeline

Actavis provides overview of standalone global pharmaceutical development pipeline